Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer

Expert Rev Gastroenterol Hepatol. 2016 Dec;10(12):1321-1340. doi: 10.1080/17474124.2016.1244003. Epub 2016 Oct 21.

Abstract

Colon cancer is common and can be considered a disease of older adults with more than half of cases diagnosed in patients aged over 70 years. Decision-making about treatment with chemotherapy for older adults may be complicated by age-related physiological changes, impaired functional status, limited social supports, concerns regarding the occurrence of and ability to tolerate treatment toxicity, and the presence of comorbidities. This is compounded by a lack of high quality evidence guiding cancer treatment decisions for older adults. Areas covered: This narrative review evaluates the evidence for adjuvant and palliative systemic therapy in older adults with colon cancer. The value of an adequate assessment prior to making a treatment decision is addressed, with emphasis on the geriatric assessment. Guidance in making a treatment decision is provided. Expert commentary: Treatment decisions should consider goals of care, a patient's treatment preferences, and weigh up relative benefits and harms.

Keywords: Colon cancer; chemotherapy; decision-making; older adult.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / mortality
  • Colonic Neoplasms / pathology
  • Comorbidity
  • Decision Support Techniques*
  • Female
  • Geriatrics / methods*
  • Health Status
  • Humans
  • Male
  • Medical Oncology / methods*
  • Middle Aged
  • Palliative Care
  • Patient Preference
  • Patient Selection
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents